Instituto de Salud Carlos III

The Institute of Health Carlos III (Instituto de Salud Carlos III,acronym in Spanish: ISCIII) is one of the main  R&D funding bodies in Spain. It is  a national public legally autonomous body created by the Spanish Parliament’s Act 14/1986, of April 25 (Ley General de Sanidad) under the title VI provisions (articles 111, 112 and 113) for the scientific and technical support of  the  National Health System (formed by the Regional Health Services) and legally entitled to promote research of quality in the field of Bio-medicine and other Health Sciences  as well as on regulatory issues (e.g on biobanking or certification of Institutes for Health Research formed  by cooperative  multi-institutional joint efforts).
It is also responsible to draft the Initiative for Health Research (= Iniciativa Sectorial de Investigación en Salud) within the R&D&I National Plans of Spain, under the Chapter IV provisions of the Spanish Parliament’s Act 16/2003, of May 28 (Ley de cohesión y calidad del Sistema Nacional de Salud). For the Plan 2008 –2011 it is defined as the Strategic Action for Health Research (= Acción Estratégica de Investigación en Salud) and structured “from the bench to the bedside” in basic, translational and applied research disease oriented, patient oriented, population oriented, early alert, pharma and health technology assessment research, as well as to foster the cooperation of the National Health System as a “platform” for developing technology with and by the industry.

Link to the website of Instituto de Salud Carlos III (ISCIII), Spain